search
Back to results

Impact of Anaesthesiology Management on Paediatric Emergence Delirium Incidence (AnaPed)

Primary Purpose

Emergence Delirium

Status
Not yet recruiting
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
Intravenous induction and desflurane anaesthesia maintenance
Inhalation induction with sevoflurane and anaesthesia maintenance with sevoflurane
Sponsored by
Brno University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Emergence Delirium focused on measuring Delirium, Emergence delirium, Paediatric patient, Anaesthesia

Eligibility Criteria

2 Years - 10 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age between 2-10 years
  • signed informed consent
  • paediatric patient for elective adenoidectomy, or adenoidectomy with micro-otoscopy and/or frenulum discission

Exclusion Criteria:

  • allergy and hypersensitivity on local anaesthetics in EMLA patch, general anaesthetics, or soya beans or peanuts
  • venepuncture refusal · neuromuscular disorder with the contraindication of inhalation anaesthetics

Sites / Locations

  • Brno University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intravenous induction with desflurane maintenance

Inhalation induction with sevoflurane,sevoflurane maintenance

Arm Description

The EMLA patch will be removed, and intravenous induction with propofol + opioid will be performed. The anaesthesia will be maintained with desflurane according to the levels of Bispectral index (BIS). Neuromuscular blockade is optional based on operator decision.

The EMLA patch will be removed, and inhalation induction with the sevoflurane will be performed. After peripheral vein cannulation, the opioid will be administered. The neuromuscular blockade is optional based on operator decision. Anaesthesia will be maintained with sevoflurane according to the set BIS levels.

Outcomes

Primary Outcome Measures

Emergence delirium incidence
The incidence of emergence delirium based on PAED score

Secondary Outcome Measures

Time to first oral intake
The interval between the end of surgery and first oral intake will be measured
Adverse events incidence
The adverse events in the postoperative period will be evaluated - postoperative nausea and vomiting, bradycardia, hypotension, anxiety
The need for concomitant medication in PACU
The need for concomitant medication in PACU - analgesic, sedative, antiemetic medication

Full Information

First Posted
February 26, 2020
Last Updated
July 26, 2023
Sponsor
Brno University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04291820
Brief Title
Impact of Anaesthesiology Management on Paediatric Emergence Delirium Incidence
Acronym
AnaPed
Official Title
Anaesthesiology Management and the Impact on Emergenece Delirium Incidence in Paediatric Patients Undergoing Adenoidectomy or Adenoidectomy With Frenulum Dicsision a/or Microotoscopy: Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 1, 2023 (Anticipated)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brno University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Postoperative emergence delirium (ED) is a severe postoperative complication in paediatric anaesthesia. ED is defined as a state with psychomotor disturbance, perception disorder and state of excitation and anxiety. The incidence of ED in paediatric patients can be up to 80%. ED is associated with the increased morbidity of paediatric patients in the postoperative period. One of the potential triggers of ED is sevoflurane. Currently, there are only limited data about comparing the influence of anesthesiologic management on the ED incidence. The possible ED reduction could lead to reduced stay in a post-anaesthesia care unit (PACU), postoperative nausea and vomiting (PONV) incidence and the overall reduction of the postoperative adverse events incidence together with the higher satisfaction and the patients and the legal guardians.
Detailed Description
This prospective randomized interventional single-blind study aims to compare the influence of the anaesthesiology management no the incidence of ED in the postoperative period in paediatric patients. Elective paediatric patients (2-10 years) scheduled for the planned adenoidectomy or adenoidectomy + micro-otoscopy/adenoidectomy + frenulum linguae discission will be included in the trial after signed informed consent form the legal guardian. In all patients, the 2 Eutectic Mixture of Local Anesthetics (EMLA) patch will be applied on the predefined skin area ( visible vein for venepuncture) between 45 minutes to 60 minutes before anaesthesia. The patients will be randomized at the operating theatre (allocation 1:1) into the experimental group (intravenous induction with propofol + opioid and anaesthesia maintenance according to this set bispectral index value with desflurane) and the control group (inhalation induction with sevoflurane mixed with air and oxygen and anaesthesia maintenance with sevoflurane). The primary aim of the study will be the incidence of ED defined by The Pediatric Anesthesia Emergence Delirium (PAED) scale, which will be measured at the , at the admission to PACU and in the 5th, 10th, 15th, 30th minute and at the moment of dismission from PACU. The secondary aim will be the time to oral intake (from the end of the surgery), the incidence of adverse events (PONV, bradycardia, hypotension), the need for concomitant medication (analgesic medication, sedative medication, antiemetic medication).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Emergence Delirium
Keywords
Delirium, Emergence delirium, Paediatric patient, Anaesthesia

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A prospective interventional single-blind randomized trial
Masking
Outcomes Assessor
Masking Description
The participants will be blinded by the arm inclusion. The outcomes will be measured by the blinded nurse in the PACU
Allocation
Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intravenous induction with desflurane maintenance
Arm Type
Experimental
Arm Description
The EMLA patch will be removed, and intravenous induction with propofol + opioid will be performed. The anaesthesia will be maintained with desflurane according to the levels of Bispectral index (BIS). Neuromuscular blockade is optional based on operator decision.
Arm Title
Inhalation induction with sevoflurane,sevoflurane maintenance
Arm Type
Active Comparator
Arm Description
The EMLA patch will be removed, and inhalation induction with the sevoflurane will be performed. After peripheral vein cannulation, the opioid will be administered. The neuromuscular blockade is optional based on operator decision. Anaesthesia will be maintained with sevoflurane according to the set BIS levels.
Intervention Type
Procedure
Intervention Name(s)
Intravenous induction and desflurane anaesthesia maintenance
Intervention Description
Anaesthesia will be inducted with intravenous propofol + opioid and maintained with desflurane according to the BIS levels
Intervention Type
Procedure
Intervention Name(s)
Inhalation induction with sevoflurane and anaesthesia maintenance with sevoflurane
Intervention Description
Anaesthesia will be inducted with sevoflurane and maintained with sevoflurane according to the BIS levels
Primary Outcome Measure Information:
Title
Emergence delirium incidence
Description
The incidence of emergence delirium based on PAED score
Time Frame
postoperative period, up to 1 hour postoperatively
Secondary Outcome Measure Information:
Title
Time to first oral intake
Description
The interval between the end of surgery and first oral intake will be measured
Time Frame
postoperative period, up to 1 hour postoperatively
Title
Adverse events incidence
Description
The adverse events in the postoperative period will be evaluated - postoperative nausea and vomiting, bradycardia, hypotension, anxiety
Time Frame
postoperative period, up to 1 hour postoperatively
Title
The need for concomitant medication in PACU
Description
The need for concomitant medication in PACU - analgesic, sedative, antiemetic medication
Time Frame
postoperative period, up to 1 hour postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age between 2-10 years signed informed consent paediatric patient for elective adenoidectomy, or adenoidectomy with micro-otoscopy and/or frenulum discission Exclusion Criteria: allergy and hypersensitivity on local anaesthetics in EMLA patch, general anaesthetics, or soya beans or peanuts venepuncture refusal · neuromuscular disorder with the contraindication of inhalation anaesthetics
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Petr Stourac, assoc.Prof.MD.Ph.D
Phone
5 3223 4261
Ext
00420
Email
stourac.petr@fnbrno.cz
First Name & Middle Initial & Last Name or Official Title & Degree
Jozef Klučka, MD
Phone
532234696
Ext
00420
Email
Klucka.jozef@fnbrno.cz
Facility Information:
Facility Name
Brno University Hospital
City
Brno
State/Province
South Moravian Region
ZIP/Postal Code
62500
Country
Czechia

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Impact of Anaesthesiology Management on Paediatric Emergence Delirium Incidence

We'll reach out to this number within 24 hrs